Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

NCT02831855 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

694

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CP-690,550
DRUG: Methotrexate
DRUG: Placebo

Sponsor

Pfizer